Literature DB >> 22565645

SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status.

L López-Corral1, M E Sarasquete, S Beà, R García-Sanz, M V Mateos, L A Corchete, J M Sayagués, E M García, J Bladé, A Oriol, M T Hernández-García, P Giraldo, J Hernández, M González, J M Hernández-Rivas, J F San Miguel, N C Gutiérrez.   

Abstract

Genetic events mediating transformation from premalignant monoclonal gammopathies (MG) to multiple myeloma (MM) are unknown. To obtain a comprehensive genomic profile of MG from the early to late stages, we performed high-resolution analysis of purified plasma cells from 20 MGUS, 20 smoldering MM (SMM) and 34 MM by high-density 6.0 SNP array. A progressive increase in the incidence of copy number abnormalities (CNA) from MGUS to SMM and to MM (median 5, 7.5 and 12 per case, respectively) was observed (P=0.006). Gains on 1q, 3p, 6p, 9p, 11q, 19p, 19q and 21q along with 1p, 16q and 22q deletions were significantly less frequent in MGUS than in MM. Although 11q and 21q gains together with 16q and 22q deletions were apparently exclusive of MM status, we observed that these abnormalities were also present in minor subclones in MGUS. Overall, a total of 65 copy number-neutral LOH (CNN-LOH) were detected. Their frequency was higher in active MM than in the asymptomatic entities (P=0.047). A strong association between genetic lesions and fragile sites was also detected. In summary, our study shows an increasing genomic complexity from MGUS to MM and identifies new chromosomal regions involved in CNA and CNN-LOH.

Entities:  

Mesh:

Year:  2012        PMID: 22565645     DOI: 10.1038/leu.2012.128

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  41 in total

Review 1.  The bone-marrow niche in MDS and MGUS: implications for AML and MM.

Authors:  Irene M Ghobrial; Alexandre Detappe; Kenneth C Anderson; David P Steensma
Journal:  Nat Rev Clin Oncol       Date:  2018-01-09       Impact factor: 66.675

2.  Progressive changes in chromatin structure and DNA damage response signals in bone marrow and peripheral blood during myelomagenesis.

Authors:  M Gkotzamanidou; E Terpos; C Bamia; S A Kyrtopoulos; P P Sfikakis; M A Dimopoulos; V L Souliotis
Journal:  Leukemia       Date:  2013-10-03       Impact factor: 11.528

3.  The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution.

Authors:  N Puig; I Conde; C Jiménez; M E Sarasquete; A Balanzategui; M Alcoceba; J Quintero; M C Chillón; E Sebastián; R Corral; L Marín; N C Gutiérrez; M-V Mateos; M González-Díaz; J F San-Miguel; R García-Sanz
Journal:  Leukemia       Date:  2015-01-08       Impact factor: 11.528

4.  Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization.

Authors:  D Grosso; E Johnson; B Colombe; O Alpdogan; M Carabasi; J Filicko-O'Hara; S Gaballa; M Kasner; T Klumpp; U Martinez-Outschoorn; J L Wagner; M Weiss; Z Wang; N Flomenberg
Journal:  Bone Marrow Transplant       Date:  2017-01-09       Impact factor: 5.483

Review 5.  MGUS to myeloma: a mysterious gammopathy of underexplored significance.

Authors:  Madhav V Dhodapkar
Journal:  Blood       Date:  2016-10-13       Impact factor: 22.113

Review 6.  Early lymphoid lesions: conceptual, diagnostic and clinical challenges.

Authors:  Karthik A Ganapathi; Stefania Pittaluga; Oreofe O Odejide; Arnold S Freedman; Elaine S Jaffe
Journal:  Haematologica       Date:  2014-09       Impact factor: 9.941

7.  How I treat smoldering multiple myeloma.

Authors:  Irene M Ghobrial; Ola Landgren
Journal:  Blood       Date:  2014-10-08       Impact factor: 22.113

Review 8.  Dilemmas in treating smoldering multiple myeloma.

Authors:  Inhye E Ahn; Sham Mailankody; Neha Korde; Ola Landgren
Journal:  J Clin Oncol       Date:  2014-11-24       Impact factor: 44.544

9.  Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies.

Authors:  Lucía López-Corral; Luis Antonio Corchete; María Eugenia Sarasquete; María Victoria Mateos; Ramón García-Sanz; Encarna Fermiñán; Juan-José Lahuerta; Joan Bladé; Albert Oriol; Ana Isabel Teruel; María Luz Martino; José Hernández; Jesús María Hernández-Rivas; Francisco Javier Burguillo; Jesús F San Miguel; Norma C Gutiérrez
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

Review 10.  Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease.

Authors:  Amit Agarwal; Irene M Ghobrial
Journal:  Clin Cancer Res       Date:  2012-12-05       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.